These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7736531)
1. Idiotypic cascades after injection of the monoclonal antibody OC125. A study in a mouse model. Schultes BC; Reinsberg J; Wagner U; Schlebusch H; Richter H; Krebs D; Biersack HJ Cell Biophys; 1994; 24-25():259-66. PubMed ID: 7736531 [TBL] [Abstract][Full Text] [Related]
2. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network. Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782 [TBL] [Abstract][Full Text] [Related]
3. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13? Reinsberg J; Krebs D Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits. Comacchio RM; Bradley J; Hohmann AW Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657 [TBL] [Abstract][Full Text] [Related]
5. Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibody. Maher VE; Drukman SJ; Kinders RJ; Hunter RE; Jennings J; Brigham C; Stevens S; Griffin TW J Immunother (1991); 1992 Jan; 11(1):56-66. PubMed ID: 1734949 [TBL] [Abstract][Full Text] [Related]
6. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody. Reinsberg J; Nocke W Eur J Clin Chem Clin Biochem; 1993 May; 31(5):323-7. PubMed ID: 8357942 [TBL] [Abstract][Full Text] [Related]
7. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer. Schlebusch H; Wagner U; Grünn U; Schultes B Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775 [TBL] [Abstract][Full Text] [Related]
9. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique. Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128 [TBL] [Abstract][Full Text] [Related]
10. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy? Fagerberg J; Frödin JE; Wigzell H; Mellstedt H Cancer Immunol Immunother; 1993 Sep; 37(4):264-70. PubMed ID: 8348565 [TBL] [Abstract][Full Text] [Related]
11. Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response. Ma J; Zhou L; Wang D Jpn J Cancer Res; 2002 Jan; 93(1):78-84. PubMed ID: 11802811 [TBL] [Abstract][Full Text] [Related]
12. Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1). Schultes BC; Baum RP; Niesen A; Noujaim AA; Madiyalakan R Cancer Immunol Immunother; 1998 Jun; 46(4):201-12. PubMed ID: 9671143 [TBL] [Abstract][Full Text] [Related]
13. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125]. Wagner U; Reinsberg J; Krebs D Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317 [TBL] [Abstract][Full Text] [Related]
14. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma. Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737 [TBL] [Abstract][Full Text] [Related]
16. Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibody. Reinsberg J; Schultes B; Wagner U; Krebs D Clin Chem; 1993 May; 39(5):891-6. PubMed ID: 8485883 [TBL] [Abstract][Full Text] [Related]
17. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)]. Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096 [TBL] [Abstract][Full Text] [Related]
18. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres. Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of anti-idiotypic antibodies and of their F(ab')2 fragments. Tassi V; Ruggiero G; Rosaia L; Lorenzoni P; Ceccarini C; Tecce MF Immunol Lett; 1991 Jan; 27(1):39-43. PubMed ID: 1708352 [TBL] [Abstract][Full Text] [Related]
20. Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3. Pohl C; Sieber M; Diehl V; Pfreundschuh M Anticancer Res; 1991; 11(3):1115-24. PubMed ID: 1653553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]